Fomivirsen (brand name Vitravene) is an antiviral drug. It is used in the treatment
of cytomegalovirus retinitis (CMV) in immunocompromised patients, including ...
Learn about the prescription medication Vitravene (Fomivirsen), drug uses,
dosage, side effects, drug interactions, warnings, reviews and patient labeling.
The trade name for Fomivirsen is Vitravene, and it is a drug manufactured by Isis
Pharmaceuticals. It is an antisense phosphorothioate oligonucleotide, a new ...
Fomivirsen Sodium Drug Information from Drugs.com. Includes Fomivirsen
Sodium side effects, interactions and indications.
Since fomivirsen blocks CMV from replicating through a different mechanism than
that of other approved CMV retinitis therapies, people who have developed ...
Vitravene 6.6 mg/ml solution for injection. 2. QUALITATIVE AND QUANTITATIVE
COMPOSITION. Each vial contains 1.65 mg of fomivirsen sodium (6.6 mg/ml).
Fomivirsen, previously known as ISIS 2922, is an approved second-line
treatment for cytomegalovirus (CMV) retinitis that is injected into the eye.
Fomivirsen is a 21 base phosphorothioate oligodeoxynucleotide. It inhibits
human cytomegalovirus (HCMV) replication by means of an antisense
A human cytomegalovirus mutant that was isolated for resistance (10-fold) to the
antisense oligonucleotide fomivirsen (ISIS 2922) exhibited cross-resistance to a ...
Aug 6, 2002 ... VITRAVENE (fomivirsen). WITHDRAWAL OF THE MARKETING
AUTHORISATION IN THE EUROPEAN UNION. On 29 July 1999 the European ...